Abstract:The removal from the marketplace of several widely prescribed drugs due to hepatotoxicity has attracted considerable attention. Now under extensive review are means by which we can better identify hepatic risk prior to federal approval. Assessment of risk-to-benefit ratios regarding a novel agent with hepatotoxicity issues (especially one for a life-threatening condition) requires considerable judgment and education on the part of prescribers and patients. The spectrum of drug-induced liver injury is broad with simulation of almost all unknown liver disorders. Drug-induced liver injuries often have a somewhat characteristic signature, as regards type of injury (hepatocellular vs cholestatic) and time of onset. The diagnosis of drug-induced liver injury is often one of exclusion with initial suspicion based on circumstantial evidence. Factors affecting susceptibility to drug-induced injury include age, sex, concomitant use of other drugs, and genetic polymorphism in metabolic pathways involved in activation or disposition of therapeutic drugs. Drug-drug interactions present particular problems in patients, often elderly, who are receiving several drugs simultaneously. Mechanisms of drug-induced liver injury are many and varied. With many drugs, intermediary products produced during metabolism are highly reactive and toxic. In these situations, the balance between the rate of production of the metabolite and the effectiveness of the drug may determine whether or not hepatic injury occurs.

Pathogenesis and Clinical Characteristic and Susceptible Factors of Drug-Induced Liver Injury

A Statistical Analysis of 28 Cases of Drug Induced Hepatitis

A new prognostic model for drug-induced liver injury especially suitable for Chinese population

Research advances in the pathogenesis of drug-induced liver injury

[The Clinical Features and Prognosis of Drug-Induced Liver Disease].

Clinial Analysis about Drug-Induced Liver Disease(51 Cases)

Progress in research on the pathogenesis of immune regulation and idiosyncratic drug-induced liver injury

Progress in the Research on Drug/Chemicals-induced Liver Injury

Overview of Research on Drug-induced Liver Injury

Dissecting the molecular pathophysiology of drug-induced liver injury

THE SUSCEPTIVITY AND PATHOGENESY OF DRUG-INDUCED LIVER DISEASE

Mechanism of drug-induced liver injury and hepatoprotective effects of natural drugs

Role of Gut Microecology in the Pathogenesis of Drug-Induced Liver Injury and Emerging Therapeutic Strategies

Clinical Analysis of Acute Drug-induced Liver Disease in 275 Cases

Advances in drug-induced liver injury research: in vitro models, mechanisms, omics and gene modulation techniques

Retrospective analysis of drug-induced liver injury

Prevention and treatment current situation of drug-induced liver Injury

Research Advances in the Association of Drug-Induced Liver Injury with Polymorphisms in Human Leukocyte Antigen.

Discussion on influence factors, mechanism and traditional Chinese medicine pathogenesis of idiosyncratic drug-induced liver injury

Drug-induced hepatotoxicity: 2005

Drug-induced liver injury:metabolic and genetic basis